Chemcrux Enterprises (BOM:540395) ROCE % : 9.75% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Chemcrux Enterprises ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Chemcrux Enterprises's annualized ROCE % for the quarter that ended in Dec. 2024 was 9.75%.

Chemcrux Enterprises ROCE % Historical Data

The historical data trend for Chemcrux Enterprises's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemcrux Enterprises ROCE % Chart

Chemcrux Enterprises Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

47.23

31.31

39.76

29.63

13.77

Chemcrux Enterprises Quarterly Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Jun21	Sep21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															19.98	9.48	7.81	7.73	9.75

Chemcrux Enterprises ROCE % Calculation

Chemcrux Enterprises's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	121.375	/	( ( (932.185 - 138.427)	+	(1098.668 - 129.549) )	/ 2 )
	=	121.375	/	( (793.758	+	969.119)	/ 2 )
	=	121.375	/	881.4385
	=	13.77 %

Chemcrux Enterprises's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	94.96	/	( ( (1164.547 - 190.226)	+	(0 - 0) )	/ 1 )
	=	94.96	/	( ( 974.321	+	0 )	/ 1 )
	=	94.96	/	974.321
	=	9.75 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Chemcrux Enterprises (BOM:540395) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Chemcrux Enterprises ROCE % Related Terms

Thank you for viewing the detailed overview of Chemcrux Enterprises's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemcrux Enterprises Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Chemcrux Enterprises Ltd (BOM:540395) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Natubhai Circle, 330, Trivia Complex, Racecourse, Vadodara, GJ, IND, 390007

Website

https://www.chemcrux.com

Chemcrux Enterprises Ltd is a chemical company in India. The company is involved in the manufacturing and processing of Bulk Drug Intermediates such as Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide. It operates in the single segment of Manufacturing of Specialty Chemicals, which includes intermediates for bulk drugs (API), as well as the dyes and pigment industries segment.

Chemcrux Enterprises Headlines

No Headlines